NEUMO congratulates BioNTech on receiving EMA Permit at Marburg plant


NEUMO GmbH + Co. KG is pleased about the rapid and successful establishment of further production capacities for vaccines against COVID-19 in Germany and Europe and supports these in many places through subcontracting in the field of vessel and tubing technology. The NEUMO Ehrenberg Group has also supported the establishment of new production capacities at many pharmaceutical companies worldwide through our subsidiaries in the USA, China, Israel, Spain and France by providing supplies.
NEUMO congratulates BioNTech on receiving approval from the European Medicines Agency (EMA) to manufacture the COVID-19 vaccine at the BioNTech faciltiy in Marburg, Germany on March 26th, 2021.
Further information can be found HERE